In addition, TP53, EGFR, AKT1, MYC, VEGFA, INS, IL6, HRAS, PTEN, and CCND1 were shown as the most potential therapeutic targets of lung cancer, and they were considered as hub genes. This evidence concerns the gene HRAS and lung carcinoma.